---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000003"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:46:32.609548+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q4 revenue $1.26B beats high end; FY2026 outlook $5.16-5.25B; new CEO Jake Leach

## Summary
- Q4 total revenue ~$1.260B (+13% YoY), US $892M (+11%), Intl $368M (+18%).
- FY2025 revenue ~$4.662B (+16%); reiterates non-GAAP gross margin ~61%, operating margin 20-21%.
- FY2026 revenue guidance $5.16-5.25B (+11-13%); non-GAAP gross margin 63-64%, operating margin 22-23%.
- Jake Leach assumed CEO role Jan 1, 2026, succeeding Kevin Sayer; presents at JPM conference.
- Stelo app reimagined with AI; G7 15 Day system shipping to pharmacies.

## SEC filing metadata
- accession: 0001093557-26-000003
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000003/0001093557-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000003/dxcm-20260107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000003
- JSON: https://secwatch.observer/filing/0001093557-26-000003.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.